CompletedNCT03524976
Treatment of Dural Arteriovenous Fistulas With SQUID™ Liquid Embolic Agent
Studying Dural sinus malformation with arteriovenous shunt
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Dr. Markus Alfred Möhlenbruch
- Principal Investigator
- Markus Moehlenbruch, PD Dr.University Hospital Heidelberg
- Intervention
- Squid(device)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2020
Study locations (7)
- Klnikum Augsburg, Augsburg, Germany
- Klinische und interventionelle Neuroradiologie Vivantes Klinikum Neukölln, Berlin, Germany
- Charité-Universitätsmedizin Berlin, Berlin, Germany
- University Clinic Bochum, Bochum, Germany
- Alfried Krupp Krankenhaus Rüttenscheid, Essen, Germany
- Klinik für Neuroradiologie Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany
- LMU Klinikum der Universität München, München, Germany
Collaborators
University Hospital Schleswig-Holstein
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03524976 on ClinicalTrials.gov